CJC-1295/Ipamorelin Vial

$450.00

CJC-1295/Ipamorelin is a synergistic growth hormone–supporting peptide blend that may enhance natural growth hormone release through dual-pathway stimulation of the pituitary. CJC-1295 (a GHRH analog) helps increase growth hormone signaling duration, while Ipamorelin (a selective ghrelin receptor agonist) promotes pulsatile GH release—working together to support optimized hormone output.

✅ May support increased natural growth hormone production

✅ May promote lean muscle development and improved body composition

✅ May aid recovery, performance, and training output

✅ May support enhanced sleep quality and overnight recovery

✅ May help improve overall vitality and metabolic efficiency

Note: A complimentary health screening is required before your first order can be fulfilled. After purchase, you’ll receive instructions to complete the intake either right away or at a scheduled time. The screening helps determine whether use may be appropriate and, once completed, remains valid for 12 months.

Description

CJC-1295/Ipamorelin works through two complementary growth hormone pathways involved in pituitary signaling.

CJC-1295 activates growth hormone–releasing hormone (GHRH) receptors, helping extend and amplify natural growth hormone pulses. Ipamorelin selectively stimulates the ghrelin (GHS-R1a) receptor, triggering additional pulsatile growth hormone release without significantly increasing cortisol or prolactin.

Together, this dual-pathway activation supports enhanced endogenous GH output and downstream IGF-1 activity—contributing to improved recovery, body composition, and overall performance support.

The combined GHRH + ghrelin receptor stimulation gives CJC-1295/Ipamorelin its “dual-agonist” growth hormone–support profile—offering a more synergistic effect than using either a standalone GHRH analog or a single growth hormone secretagogue alone.

Additional information

Shop by Goal